Aoife Brennan

Track

Insider profile

Currently holds a position at Synlogic Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Synlogic Inc Oct. 1, 2018 -
Interim President and Chief Executive Officer, Chief Medical Officer Synlogic Inc May 10, 2018 - Oct. 1, 2018
Chief Medical Officer Synlogic Inc Aug. 28, 2017 - May 10, 2018
Aoife Brennan's trades of Climb Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
280.23
Quantity 40,239 -42.1%
Value US$2,077,620
US Climb Bio Inc (CLYM)
Transaction date
Proposed sale
Price
169.25
Quantity 86,832
Value US$2,245,820
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
307.31
Quantity 65,174 -7.1%
Value US$4,333,479
US Synlogic Inc (SYBX)
Transaction date
Proposed sale
Price
1.83
Quantity 88,293
Value US$161,576
US Synlogic Inc (SYBX)
Transaction date
Proposed sale
Price
1.73
Quantity 6,868
Value US$11,881
US FibroGen Inc (FGEN)
Transaction date
Proposed sale
Price
17.19
Quantity 4,733
Value US$81,363
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
17.52
Quantity 2,739 -8.9%
Value US$47,987
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
16.74
Quantity 1,994 -6.1%
Value US$33,380
US Synlogic Inc (SYBX)
Transaction date
Planned sale
Price
0.58
Quantity 19,042 -6.9%
Value US$10,964
US Synlogic Inc (SYBX)
Transaction date
Planned sale
Price
2.45
Quantity 8,894 -3.1%
Value US$21,754
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-29
US Climb Bio Inc (CLYM)
PlS Planned sale
40,239 -42.1%
280.23
US$2,077,620 		40,239 -42.1% 280.23 US$2,077,620
2026-06-30 2026-06-29
US Climb Bio Inc (CLYM)
PrS Proposed sale
86,832
169.25
US$2,245,820 		86,832 169.25 US$2,245,820
2025-07-01 2025-06-30
US Climb Bio Inc (CLYM)
PlS Planned sale
65,174 -7.1%
307.31
US$4,333,479 		65,174 -7.1% 307.31 US$4,333,479
2024-04-22 2024-04-19
US Synlogic Inc (SYBX)
PrS Proposed sale
88,293
1.83
US$161,576 		88,293 1.83 US$161,576
2024-03-21 2024-03-21
US Synlogic Inc (SYBX)
PrS Proposed sale
6,868
1.73
US$11,881 		6,868 1.73 US$11,881
2023-06-09 2023-06-09
US FibroGen Inc (FGEN)
PrS Proposed sale
4,733
17.19
US$81,363 		4,733 17.19 US$81,363
2023-06-09 2023-06-09
US FibroGen Inc (FGEN)
PlS Planned sale
2,739 -8.9%
17.52
US$47,987 		2,739 -8.9% 17.52 US$47,987
2023-06-09 2023-06-09
US FibroGen Inc (FGEN)
PlS Planned sale
1,994 -6.1%
16.74
US$33,380 		1,994 -6.1% 16.74 US$33,380
2023-04-05 2023-04-03
US Synlogic Inc (SYBX)
PlS Planned sale
19,042 -6.9%
0.58
US$10,964 		19,042 -6.9% 0.58 US$10,964
2022-04-06 2022-04-04
US Synlogic Inc (SYBX)
PlS Planned sale
8,894 -3.1%
2.45
US$21,754 		8,894 -3.1% 2.45 US$21,754